Zhongtao Zhang

Dr. Zhongtao Zhang


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2020 in Cancer Management and Research
Verified
Journal Article
Open access
PDF file
LJLei Jin
Lei Jin
XMXue-Mei Ma
Xue-Mei Ma
TWTing-Ting Wang
Ting-Ting Wang
YYYao Yang
Yao Yang
NZNan Zhang
Nan Zhang
ZZZhongtao Zhang
Zhongtao Zhang
Purpose: The present study aimed to investigate the impact of psoralen on miR-196a-5p expression and function, and to reveal the mechanism underlying miR-196a-5p-mediated inhibition and the reversal of cisplatin (DDP) resistance. Methods: Serum samples were collected from 50 patients with gastric cancer (GC), and the association between miR-196a-5p expression and the response to chemotherapy was assessed. A DDP-resistant GC cell line was also established to determine the effects of miR-196a-5p and psoralen on DDP resistance. MGC803 cells were transfected with miR-196a-5p mimic and inhibitor vectors for the overexpression and downregulation of miR-196a-5p, respectively. Results: Clinical data analysis showed that the lower expression levels of miR-196a-5p were significantly associated with chemoresistance in patients with GC. Upregulation of miR-196a-5p significantly enhanced the anti-proliferative effect, apoptosis and sensitivity to DDP by regulating the protein expression levels of HOXB7, HER2, Bcl-2 and G1/S-specific cyclin-D1 (CCND1). Furthermore, psoralen reversed miR-196a-5p-induced DDP resistance and reduced the expression levels of HOXB7, HER2, Bcl-2 and CCND1. Conclusion: miR-196a-5p may be a novel biomarker of chemotherapeutic success in patients with GC and may also influence the sensitivity of GC cells to DDP. Moreover, psoralen can increase chemotherapeutic sensitivity by upregulating miR-196a-5p and then downregulating HOXB7-HER2 signaling axis.

14 April 2020 in PeerJ
Verified
Journal Article
Open access
PDF file
LJLei Jin
Lei Jin
NZNan Zhang
Nan Zhang
QZQian Zhang
Qian Zhang
GDGuoqian Ding
Guoqian Ding
ZYZhenghan Yang
Zhenghan Yang
ZZZhongtao Zhang
Zhongtao Zhang
Background: microRNAs (miRNAs) have been studied for their role in the early detection of several diseases. However, there is no current information on the systematic screening of serum-derived cisplatin resistance biomarkers in gastric cancer (GC). Methods: Cisplatin-resistant GC cell lines were screened for dysregulated miRNAs using small RNA sequencing (sRNA-seq) and miRNAs were functionally annotated using bioinformatics analyses. Real-time quantitative polymerase chain reaction (RT-qPCR) was used to validate the miRNA-relative transcription levels in GC cells and in 74 GC patients. We analyzed the associations between the clinical characteristics of the patients and their miRNA expression. Receiver operating characteristic (ROC) analysis was used to evaluate the diagnostic value for serum-derived cisplatin resistance. Results: Seven miRNAs were identified from 35 differentially expressed miRNAs between the MGC803/DDP and MGC803 cells in a public database. We found four miRNA candidates (miR-9-3p, miR-9-5p, miR-146a-5p, and miR-433-3p) that were significantly associated with chemotherapy responses in GC cells and patients. miR-9-5p (AUC = 0.856, 95% CI [0.773–0.939], p < 0.0001) and a combined group (miR-9-5p + miR-9-3p + miR-433-3p) (AUC = 0.915, 95% CI [0.856–0.975], P < 0.0001) distinguished chemoresistant GC patients from chemosensitive GC patients. Conclusions: Our study reveals the potential therapeutic use of two serum-based biomarkers, miR-9-5p and a combined group (miR-9-5p + miR-9-3p + miR-433-3p), as indicators for the successful use of cisplatin in GC patients.

1 January 2020 in Clinical Laboratory
Verified
Journal Article
Closed access
LJLei Jin
Lei Jin
ZZZhongtao Zhang
Zhongtao Zhang
Background: Systematic screening for serum-derived biomarkers of cisplatin (DDP) resistance in gastric cancer (GC) remains unreported. The current study aimed to investigate differentially expressed serum miRNAs in GC patients with DDP sensitivity and resistance and their ability to predict cisplatin treatment effectiveness. Methods: The DDP-resistant GC cell line MGC803/DDP was established for screening these dysregulated miRNAs through small RNA sequencing (sRNA-seq), and the miRNA functions were annotated by bioinformatics analysis. RT-qPCR validated the relative miRNA transcription levels in GC cells and sera from 74 GC patients. The associations between the patient clinical parameters and miRNA expression were analyzed. The diagnostic value was evaluated using receiver operating characteristic (ROC) analysis. Results: sRNA-seq identified 35 miRNAs with differential expression between MGC803/DDP cells and MGC803 cells, with miR-3180-3p as the most significantly upregulated miRNA and miR-124-3p as the most significantly downregulated miRNA in MGC803/DDP cells. Clinical data analysis showed that compared with their expression in chemosensitive patients, miR-3180-3p expression was significantly upregulated and miR-124-3p expression was downregulated in chemoresistant GC patients (both p < 0.0001). A combination of the two miRNAs effectively distinguished the chemoresistant GC patients from the chemosensitive GC patients (AUC = 0.946 +/- 0.023, 95% CI = 0.900 - 0.991, p < 0.001, SE = 85.0%, SP = 82.4%). Downregulated miR-124-3p and upregulated miR-3180-3p were significantly correlated with a high TNM stage. Conclusions: The differentially expressed circulatory markers miR-124-3p, miR-3180-3p, and their combination can serve as serum-based biomarkers to predict the therapeutic benefit of DDP in GC.

25 October 2021 in Frontiers in Surgery
Verified
Journal Article
Open access
JSJianning Song
Jianning Song
YYYingchi Yang
Yingchi Yang
WGWenxian Guan
Wenxian Guan
GJGang Jin
Gang Jin
YYYinmo Yang
Yinmo Yang
ZZZhongtao Zhang
Zhongtao Zhang
Objective: To evaluate the influence of the abdominal incision length on the gastrointestinal function recovery post-operatively.Background: Gut motility recovers more quickly after the minimally invasive laparoscopic surgery compared than after the traditional open surgery; however, whether the minimal abdominal incision contributes to the faster gut motility recovery is controversial and lacks solid clinical evidence.Methods: A registry-based secondary cohort analysis was conducted to evaluate the association between the abdominal incision length and gut motility recovery post-operatively based on a multicenter, prospective, and observational study of the prolonged post-operative ileus (PPOI) incidence and the risk factors in the patients with the major abdominal surgery. The incision length, in the centimeters, was the exposure. The primary outcome measures were the PPOI incidence and its association with the incision length. The secondary outcome included the days to the first passage of flatus and the days to the first passage of stool.Results: Overall, 1,840 patients, including 287 (15.7%) patients with the PPOI, were recruited. The PPOI incidence was 17.6% and 13.3% in the long-incision (>18 cm) and short-incision patients ( ≤ 18 cm), respectively. The incidence of the PPOI increased by 1.1% (1.0–1.1) by each centimeter increment of the incision length after adjusting for the confounding factors. In comparison to the short-incision patients, the long-incision patients had prolonged passage of stool (4.46 vs. 4.95 days, p < 0.001). Each centimeter increment of the incision length contributed to a 2% increased risk of delay in the first bowel movement [hazard ratio (HR) 0.980 (0.967, 0.994)].Conclusion: A long abdominal incision length independently contributed to the prolonged gut function recovery post-operatively mainly by delaying the time to the first bowel movement, but not influencing the time to first passage of flatus.

19 August 2023 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
JYJunhui Yu
Junhui Yu
YBYanyan Bai
Yanyan Bai
LJLan Jin
Lan Jin
ZZZhongtao Zhang
Zhongtao Zhang
YYYingchi Yang
Yingchi Yang